The moral efficiency of clinical trials in anti-cancer drug development

Carlisle, B.G. The moral efficiency of clinical trials in anti-cancer drug development. PhD Thesis, McGill University, Montréal Québec, 2019.Download
Appendices A-GDownload
Appendix H (chapter 1)Download
Appendix I (chapter 2)Download
Appendix J (chapter 3, trials)Download
Appendix K (chapter 3, trajectories)Download
Appendix L (chapter 4, trials)Download
Appendix M (chapter 4, pairings)Download
Appendix N (chapter 4, OS)Download
Appendix O Chapter 4, PFSDownload
Appendix P Chapter 4, G3-4 SAEDownload
Appendix Q Chapter 4, G5 SAEDownload

Published by

The Grey Literature

This is the personal blog of Benjamin Gregory Carlisle PhD. Queer; Academic; Queer academic. "I'm the research fairy, here to make your academic problems disappear!"

2 thoughts on “The moral efficiency of clinical trials in anti-cancer drug development”

  1. Pingback: There’s another reason why Pfizer actually did the right thing with Enbrel in Alzheimer’s – The Grey Literature
  2. Pingback: Clinical agnosticism and when trials say “maybe”—a presentation for #SummerSchool hosted by scholar.social – The Grey Literature

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.